<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on September 20, 2023</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/ct2/show/NCT03294720</url>
  </required_header>
  <id_info>
    <org_study_id>BioACL (CS)</org_study_id>
    <nct_id>NCT03294720</nct_id>
  </id_info>
  <brief_title>BioACL Reconstruction With Amnion Collagen Matrix Wrap and Stem Cells Case Series</brief_title>
  <acronym>BioACL(CS)</acronym>
  <official_title>Augmentation of ACL Reconstruction With Bone Marrow Stem Cells and Amnion Collagen Matrix Wrap: a Case Series</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Andrews Research &amp; Education Foundation</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Arthrex, Inc.</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>Andrews Research &amp; Education Foundation</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>Yes</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      The objective of this study is to evaluate the use of wrapping an ACL graft with a collagen&#xD;
      matrix tissue wrap and injecting autologous bone marrow aspirate concentrate under the&#xD;
      wrapping and into the graft. Investigators hypothesize that this method of augmenting ACL&#xD;
      surgery will accelerate and improve the graft maturation and ligamentization process.&#xD;
      Investigators propose to test this hypothesis with a series of cases of ACL reconstructions&#xD;
      evaluated with post-operative MRI mapping sequences and validated clinical outcome measures&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Histologic studies have determined that graft ligamentization following anterior cruciate&#xD;
      ligament (ACL) reconstruction may take from 6 to 18 months. (1) It has been reported that&#xD;
      incomplete graft maturation and incorporation is one cause of clinical graft failure. Animal&#xD;
      studies have illustrated improved tendon healing/integration in ACL models augmented with&#xD;
      stem cell technologies. (2-4). Basic scientists theorize that optimization of stem cell&#xD;
      treatments for tissue regeneration requires that a &quot;regenerative triad&quot; be employed, i.e.,&#xD;
      use of a scaffold, stem cells and growth factors. In the intra-articular environment,&#xD;
      research has shown that a scaffold such as an amnion wrap is necessary to contain the stem&#xD;
      cells and growth factors in close proximity to the ACL graft. (2, 4, 5) The normal, uninjured&#xD;
      human ACL is covered by a layer of synovial tissue which contributes to the blood supply and&#xD;
      nutrition of the native ACL. It is theorized that the lack of a synovial lining after injury&#xD;
      and following traditional ACL reconstruction contributes to slow ligamentization and possible&#xD;
      failure of reconstructed grafts.(5) Two studies have demonstrated accelerated maturation and&#xD;
      ligamentization of human ACL graft augmented with point of care blood products. (6, 7) In&#xD;
      one, leucocyte poor platelet rich plasma was injected directly into the body of the graft.&#xD;
      (6) In the other, the platelet derived growth factors were loaded in a gelatin carrier which&#xD;
      was wrapped around the graft. (7) In both studies accelerated and increased ligament&#xD;
      maturation was documented compared to the controls. Collagen membranes derived from amniotic&#xD;
      tissue have been successful to aid healing when used in difficult wounds and meniscal repair&#xD;
      surgery. (8, 9) Investigators believe that use of a collagen based -membrane derived from&#xD;
      amniotic tissue can be used to help reestablish the natural synovial lining of the&#xD;
      reconstructed ACL, in effect acting as both a barrier from the synovial fluid and as a&#xD;
      scaffold to contain autologous mesenchymal stem cells and growth factors contiguous with the&#xD;
      graft, thus aiding and perhaps accelerating the natural maturation and ligamentization&#xD;
      process of the implanted graft tissue. Acceleration and improvement in graft maturation and&#xD;
      strength would be a significant advancement in sports medicine allowing safer and earlier&#xD;
      return to sports and activity.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">January 8, 2018</start_date>
  <completion_date type="Actual">December 31, 2022</completion_date>
  <primary_completion_date type="Actual">August 31, 2022</primary_completion_date>
  <phase>Phase 1</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <intervention_model_description>Normal ACL reconstruction with either patellar or hamstring autograft will be done and prior to fixation the graft will be wrapped in a amion collagen wrap. Bone marrow aspirate will be obtained from distal femur at the time of the arthroscopy and stem cells isolated using the Arthrex Angel System. These stem cells with be under direct visualization impregnated into the ACL autograft amion wrap complex.</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>MRI graft maturation and integration</measure>
    <time_frame>3 months, 6 months, 9 months, and 12 months post-op</time_frame>
    <description>validated T2 star sequence which will undergo region of interest mapping to produce mean T2 values. These values have been shown to detect differences in ACL content, structure and maturation.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Changes in patient-reported pain rating</measure>
    <time_frame>3 months, 6 months, 9 months, 12 months post-op</time_frame>
    <description>Visual analog scale will be used to assess pain</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Changes in Knee injury and Osteoarthritis Outcome Score (KOOS)</measure>
    <time_frame>3 months, 6 months, 9 months, 12 months post-op</time_frame>
    <description>Patients will complete KOOS questionnaire on SOS</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Changes in Short Form 12 (SF-12) patient ratings</measure>
    <time_frame>3 months, 6 months, 9 months, 12 months post-op</time_frame>
    <description>Patients will complete SF-12 questionnaire on SOS</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Changes in Single Assessment Numerical Evaluation (SANE) patient ratings for function</measure>
    <time_frame>3 months, 6 months, 9 months, 12 months post-op</time_frame>
    <description>Patients will complete the SANE questionnaire on SOS</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Marx Activity Scale Rating</measure>
    <time_frame>3 months, 6 months, 9 months, 12 months post-op</time_frame>
    <description>Patients will complete the Marx Activity questionnaire on SOS</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">10</enrollment>
  <condition>ACL - Anterior Cruciate Ligament Rupture</condition>
  <arm_group>
    <arm_group_label>Bio ACL Reconstruction</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Normal ACL reconstruction with either patellar or hamstring autograft will be done and prior to fixation the graft will be wrapped in a amion collagen wrap. Bone marrow aspirate will be obtained from distal femur at the time of the arthroscopy and stem cells isolated using the Arthrex Angel System. These stem cells with be under direct visualization impregnated into the ACL autograft amion wrap complex.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Bio-ACL</intervention_name>
    <description>ACL reconstruction with either hamstring or patellar autograft, wrapped in amion collagen wrap, and stem cells from bone marrow aspirate.</description>
    <arm_group_label>Bio ACL Reconstruction</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>amnion wrap and BMAC</intervention_name>
    <description>amnion collagen wrap and bone-marrow aspirate in ACL reconstruction autograft</description>
    <arm_group_label>Bio ACL Reconstruction</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Patients between the ages of 18 and 35 who are scheduled to have anterior cruciate&#xD;
             ligament reconstruction with autologous grafts by the principal investigator will be&#xD;
             screened for participation in this study.&#xD;
&#xD;
          -  Patients must be willing to undergo MRI scans post -operatively at 3, 6, 9 months and&#xD;
             1 year.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Patients with prior procedures or significant prior injuries to the same knee are&#xD;
             excluded. Any patient who will have difficulty obtaining internet access, does not&#xD;
             have an active e-mail address, or is unable to comprehend study documents or give&#xD;
             informed consent will be excluded.&#xD;
&#xD;
          -  Patient who are unable to complete MRI examinations due to claustrophobia or anxiety&#xD;
             will be excluded.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>35 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Adam Anz, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Andrews Insituite for Sports and Orthopaedics</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Andrews Institute</name>
      <address>
        <city>Gulf Breeze</city>
        <state>Florida</state>
        <zip>32561</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <reference>
    <citation>Claes S, Verdonk P, Forsyth R, Bellemans J. The &quot;ligamentization&quot; process in anterior cruciate ligament reconstruction: what happens to the human graft? A systematic review of the literature. Am J Sports Med. 2011 Nov;39(11):2476-83. doi: 10.1177/0363546511402662. Epub 2011 Apr 22.</citation>
    <PMID>21515806</PMID>
  </reference>
  <reference>
    <citation>Jang KM, Lim HC, Jung WY, Moon SW, Wang JH. Efficacy and Safety of Human Umbilical Cord Blood-Derived Mesenchymal Stem Cells in Anterior Cruciate Ligament Reconstruction of a Rabbit Model: New Strategy to Enhance Tendon Graft Healing. Arthroscopy. 2015 Aug;31(8):1530-9. doi: 10.1016/j.arthro.2015.02.023. Epub 2015 Apr 14.</citation>
    <PMID>25882182</PMID>
  </reference>
  <reference>
    <citation>Matsumoto T, Kubo S, Sasaki K, Kawakami Y, Oka S, Sasaki H, Takayama K, Tei K, Matsushita T, Mifune Y, Kurosaka M, Kuroda R. Acceleration of tendon-bone healing of anterior cruciate ligament graft using autologous ruptured tissue. Am J Sports Med. 2012 Jun;40(6):1296-302. doi: 10.1177/0363546512439026. Epub 2012 Mar 16.</citation>
    <PMID>22427618</PMID>
  </reference>
  <reference>
    <citation>Mifune Y, Matsumoto T, Takayama K, Terada S, Sekiya N, Kuroda R, Kurosaka M, Fu FH, Huard J. Tendon graft revitalization using adult anterior cruciate ligament (ACL)-derived CD34+ cell sheets for ACL reconstruction. Biomaterials. 2013 Jul;34(22):5476-87. doi: 10.1016/j.biomaterials.2013.04.013. Epub 2013 Apr 28.</citation>
    <PMID>23632324</PMID>
  </reference>
  <reference>
    <citation>Joshi SM, Mastrangelo AN, Magarian EM, Fleming BC, Murray MM. Collagen-platelet composite enhances biomechanical and histologic healing of the porcine anterior cruciate ligament. Am J Sports Med. 2009 Dec;37(12):2401-10. doi: 10.1177/0363546509339915.</citation>
    <PMID>19940313</PMID>
  </reference>
  <reference>
    <citation>Sanchez M, Anitua E, Azofra J, Prado R, Muruzabal F, Andia I. Ligamentization of tendon grafts treated with an endogenous preparation rich in growth factors: gross morphology and histology. Arthroscopy. 2010 Apr;26(4):470-80. doi: 10.1016/j.arthro.2009.08.019. Epub 2010 Jan 15.</citation>
    <PMID>20362825</PMID>
  </reference>
  <reference>
    <citation>Radice F, Yanez R, Gutierrez V, Rosales J, Pinedo M, Coda S. Comparison of magnetic resonance imaging findings in anterior cruciate ligament grafts with and without autologous platelet-derived growth factors. Arthroscopy. 2010 Jan;26(1):50-7. doi: 10.1016/j.arthro.2009.06.030.</citation>
    <PMID>20117627</PMID>
  </reference>
  <reference>
    <citation>DiDomenico LA, Orgill DP, Galiano RD, Serena TE, Carter MJ, Kaufman JP, Young NJ, Zelen CM. Aseptically Processed Placental Membrane Improves Healing of Diabetic Foot Ulcerations: Prospective, Randomized Clinical Trial. Plast Reconstr Surg Glob Open. 2016 Oct 12;4(10):e1095. doi: 10.1097/GOX.0000000000001095. eCollection 2016 Oct.</citation>
    <PMID>27826487</PMID>
  </reference>
  <reference>
    <citation>Piontek T, Ciemniewska-Gorzela K, Naczk J, Jakob R, Szulc A, Grygorowicz M, Slomczykowski M. Complex Meniscus Tears Treated with Collagen Matrix Wrapping and Bone Marrow Blood Injection: A 2-Year Clinical Follow-Up. Cartilage. 2016 Apr;7(2):123-39. doi: 10.1177/1947603515608988. Epub 2015 Nov 30.</citation>
    <PMID>27047635</PMID>
  </reference>
  <reference>
    <citation>Li J, Wang J, Li Y, Shao D, You X, Shen Y. A Prospective Randomized Study of Anterior Cruciate Ligament Reconstruction With Autograft, gamma-Irradiated Allograft, and Hybrid Graft. Arthroscopy. 2015 Jul;31(7):1296-302. doi: 10.1016/j.arthro.2015.02.033. Epub 2015 Apr 17.</citation>
    <PMID>25891223</PMID>
  </reference>
  <reference>
    <citation>Biercevicz AM, Akelman MR, Fadale PD, Hulstyn MJ, Shalvoy RM, Badger GJ, Tung GA, Oksendahl HL, Fleming BC. MRI volume and signal intensity of ACL graft predict clinical, functional, and patient-oriented outcome measures after ACL reconstruction. Am J Sports Med. 2015 Mar;43(3):693-9. doi: 10.1177/0363546514561435. Epub 2014 Dec 24.</citation>
    <PMID>25540298</PMID>
  </reference>
  <reference>
    <citation>Riboh JC, Saltzman BM, Yanke AB, Cole BJ. Human Amniotic Membrane-Derived Products in Sports Medicine: Basic Science, Early Results, and Potential Clinical Applications. Am J Sports Med. 2016 Sep;44(9):2425-34. doi: 10.1177/0363546515612750. Epub 2015 Nov 19.</citation>
    <PMID>26585668</PMID>
  </reference>
  <reference>
    <citation>Beitzel K, McCarthy MB, Cote MP, Chowaniec D, Falcone LM, Falcone JA, Dugdale EM, Deberardino TM, Arciero RA, Mazzocca AD. Rapid isolation of human stem cells (connective progenitor cells) from the distal femur during arthroscopic knee surgery. Arthroscopy. 2012 Jan;28(1):74-84. doi: 10.1016/j.arthro.2011.06.035. Epub 2011 Oct 11.</citation>
    <PMID>21996407</PMID>
  </reference>
  <verification_date>January 2023</verification_date>
  <study_first_submitted>September 20, 2017</study_first_submitted>
  <study_first_submitted_qc>September 22, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">September 27, 2017</study_first_posted>
  <last_update_submitted>January 30, 2023</last_update_submitted>
  <last_update_submitted_qc>January 30, 2023</last_update_submitted_qc>
  <last_update_posted type="Actual">February 1, 2023</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Rupture</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>


download date: ClinicalTrials.gov processed this data on September 20, 2023
link text: Link to the current ClinicalTrials.gov record.
url: https://clinicaltrials.gov/ct2/show/NCT03294720
org study id: BioACL (CS)
nct id: NCT03294720
lead sponsor: 
collaborator: 
has dmc: Yes
is fda regulated drug: Yes
is fda regulated device: No
is us export: No
The objective of this study is to evaluate the use of wrapping an ACL graft with a collagen
      matrix tissue wrap and injecting autologous bone marrow aspirate concentrate under the
      wrapping and into the graft. Investigators hypothesize that this method of augmenting ACL
      surgery will accelerate and improve the graft maturation and ligamentization process.
      Investigators propose to test this hypothesis with a series of cases of ACL reconstructions
      evaluated with post-operative MRI mapping sequences and validated clinical outcome measures
Histologic studies have determined that graft ligamentization following anterior cruciate
      ligament (ACL) reconstruction may take from 6 to 18 months. (1) It has been reported that
      incomplete graft maturation and incorporation is one cause of clinical graft failure. Animal
      studies have illustrated improved tendon healing/integration in ACL models augmented with
      stem cell technologies. (2-4). Basic scientists theorize that optimization of stem cell
      treatments for tissue regeneration requires that a "regenerative triad" be employed, i.e.,
      use of a scaffold, stem cells and growth factors. In the intra-articular environment,
      research has shown that a scaffold such as an amnion wrap is necessary to contain the stem
      cells and growth factors in close proximity to the ACL graft. (2, 4, 5) The normal, uninjured
      human ACL is covered by a layer of synovial tissue which contributes to the blood supply and
      nutrition of the native ACL. It is theorized that the lack of a synovial lining after injury
      and following traditional ACL reconstruction contributes to slow ligamentization and possible
      failure of reconstructed grafts.(5) Two studies have demonstrated accelerated maturation and
      ligamentization of human ACL graft augmented with point of care blood products. (6, 7) In
      one, leucocyte poor platelet rich plasma was injected directly into the body of the graft.
      (6) In the other, the platelet derived growth factors were loaded in a gelatin carrier which
      was wrapped around the graft. (7) In both studies accelerated and increased ligament
      maturation was documented compared to the controls. Collagen membranes derived from amniotic
      tissue have been successful to aid healing when used in difficult wounds and meniscal repair
      surgery. (8, 9) Investigators believe that use of a collagen based -membrane derived from
      amniotic tissue can be used to help reestablish the natural synovial lining of the
      reconstructed ACL, in effect acting as both a barrier from the synovial fluid and as a
      scaffold to contain autologous mesenchymal stem cells and growth factors contiguous with the
      graft, thus aiding and perhaps accelerating the natural maturation and ligamentization
      process of the implanted graft tissue. Acceleration and improvement in graft maturation and
      strength would be a significant advancement in sports medicine allowing safer and earlier
      return to sports and activity.
allocation: N/A
intervention model: Single Group Assignment
intervention model description: Normal ACL reconstruction with either patellar or hamstring autograft will be done and prior to fixation the graft will be wrapped in a amion collagen wrap. Bone marrow aspirate will be obtained from distal femur at the time of the arthroscopy and stem cells isolated using the Arthrex Angel System. These stem cells with be under direct visualization impregnated into the ACL autograft amion wrap complex.
primary purpose: Treatment
masking: None (Open Label)
measure: MRI graft maturation and integration
time frame: 3 months, 6 months, 9 months, and 12 months post-op
description: validated T2 star sequence which will undergo region of interest mapping to produce mean T2 values. These values have been shown to detect differences in ACL content, structure and maturation.
measure: Changes in patient-reported pain rating
time frame: 3 months, 6 months, 9 months, 12 months post-op
description: Visual analog scale will be used to assess pain
measure: Changes in Knee injury and Osteoarthritis Outcome Score (KOOS)
time frame: 3 months, 6 months, 9 months, 12 months post-op
description: Patients will complete KOOS questionnaire on SOS
measure: Changes in Short Form 12 (SF-12) patient ratings
time frame: 3 months, 6 months, 9 months, 12 months post-op
description: Patients will complete SF-12 questionnaire on SOS
measure: Changes in Single Assessment Numerical Evaluation (SANE) patient ratings for function
time frame: 3 months, 6 months, 9 months, 12 months post-op
description: Patients will complete the SANE questionnaire on SOS
measure: Marx Activity Scale Rating
time frame: 3 months, 6 months, 9 months, 12 months post-op
description: Patients will complete the Marx Activity questionnaire on SOS
arm group label: Bio ACL Reconstruction
arm group type: Experimental
description: Normal ACL reconstruction with either patellar or hamstring autograft will be done and prior to fixation the graft will be wrapped in a amion collagen wrap. Bone marrow aspirate will be obtained from distal femur at the time of the arthroscopy and stem cells isolated using the Arthrex Angel System. These stem cells with be under direct visualization impregnated into the ACL autograft amion wrap complex.
intervention type: Procedure
intervention name: Bio-ACL
description: ACL reconstruction with either hamstring or patellar autograft, wrapped in amion collagen wrap, and stem cells from bone marrow aspirate.
arm group label: Bio ACL Reconstruction
intervention type: Device
intervention name: amnion wrap and BMAC
description: amnion collagen wrap and bone-marrow aspirate in ACL reconstruction autograft
arm group label: Bio ACL Reconstruction
criteria: 
gender: All
minimum age: 18 Years
maximum age: 35 Years
healthy volunteers: Accepts Healthy Volunteers
last name: Adam Anz, MD
role: Principal Investigator
affiliation: Andrews Insituite for Sports and Orthopaedics
facility: 
country: United States
citation: Claes S, Verdonk P, Forsyth R, Bellemans J. The "ligamentization" process in anterior cruciate ligament reconstruction: what happens to the human graft? A systematic review of the literature. Am J Sports Med. 2011 Nov;39(11):2476-83. doi: 10.1177/0363546511402662. Epub 2011 Apr 22.
PMID: 21515806
citation: Jang KM, Lim HC, Jung WY, Moon SW, Wang JH. Efficacy and Safety of Human Umbilical Cord Blood-Derived Mesenchymal Stem Cells in Anterior Cruciate Ligament Reconstruction of a Rabbit Model: New Strategy to Enhance Tendon Graft Healing. Arthroscopy. 2015 Aug;31(8):1530-9. doi: 10.1016/j.arthro.2015.02.023. Epub 2015 Apr 14.
PMID: 25882182
citation: Matsumoto T, Kubo S, Sasaki K, Kawakami Y, Oka S, Sasaki H, Takayama K, Tei K, Matsushita T, Mifune Y, Kurosaka M, Kuroda R. Acceleration of tendon-bone healing of anterior cruciate ligament graft using autologous ruptured tissue. Am J Sports Med. 2012 Jun;40(6):1296-302. doi: 10.1177/0363546512439026. Epub 2012 Mar 16.
PMID: 22427618
citation: Mifune Y, Matsumoto T, Takayama K, Terada S, Sekiya N, Kuroda R, Kurosaka M, Fu FH, Huard J. Tendon graft revitalization using adult anterior cruciate ligament (ACL)-derived CD34+ cell sheets for ACL reconstruction. Biomaterials. 2013 Jul;34(22):5476-87. doi: 10.1016/j.biomaterials.2013.04.013. Epub 2013 Apr 28.
PMID: 23632324
citation: Joshi SM, Mastrangelo AN, Magarian EM, Fleming BC, Murray MM. Collagen-platelet composite enhances biomechanical and histologic healing of the porcine anterior cruciate ligament. Am J Sports Med. 2009 Dec;37(12):2401-10. doi: 10.1177/0363546509339915.
PMID: 19940313
citation: Sanchez M, Anitua E, Azofra J, Prado R, Muruzabal F, Andia I. Ligamentization of tendon grafts treated with an endogenous preparation rich in growth factors: gross morphology and histology. Arthroscopy. 2010 Apr;26(4):470-80. doi: 10.1016/j.arthro.2009.08.019. Epub 2010 Jan 15.
PMID: 20362825
citation: Radice F, Yanez R, Gutierrez V, Rosales J, Pinedo M, Coda S. Comparison of magnetic resonance imaging findings in anterior cruciate ligament grafts with and without autologous platelet-derived growth factors. Arthroscopy. 2010 Jan;26(1):50-7. doi: 10.1016/j.arthro.2009.06.030.
PMID: 20117627
citation: DiDomenico LA, Orgill DP, Galiano RD, Serena TE, Carter MJ, Kaufman JP, Young NJ, Zelen CM. Aseptically Processed Placental Membrane Improves Healing of Diabetic Foot Ulcerations: Prospective, Randomized Clinical Trial. Plast Reconstr Surg Glob Open. 2016 Oct 12;4(10):e1095. doi: 10.1097/GOX.0000000000001095. eCollection 2016 Oct.
PMID: 27826487
citation: Piontek T, Ciemniewska-Gorzela K, Naczk J, Jakob R, Szulc A, Grygorowicz M, Slomczykowski M. Complex Meniscus Tears Treated with Collagen Matrix Wrapping and Bone Marrow Blood Injection: A 2-Year Clinical Follow-Up. Cartilage. 2016 Apr;7(2):123-39. doi: 10.1177/1947603515608988. Epub 2015 Nov 30.
PMID: 27047635
citation: Li J, Wang J, Li Y, Shao D, You X, Shen Y. A Prospective Randomized Study of Anterior Cruciate Ligament Reconstruction With Autograft, gamma-Irradiated Allograft, and Hybrid Graft. Arthroscopy. 2015 Jul;31(7):1296-302. doi: 10.1016/j.arthro.2015.02.033. Epub 2015 Apr 17.
PMID: 25891223
citation: Biercevicz AM, Akelman MR, Fadale PD, Hulstyn MJ, Shalvoy RM, Badger GJ, Tung GA, Oksendahl HL, Fleming BC. MRI volume and signal intensity of ACL graft predict clinical, functional, and patient-oriented outcome measures after ACL reconstruction. Am J Sports Med. 2015 Mar;43(3):693-9. doi: 10.1177/0363546514561435. Epub 2014 Dec 24.
PMID: 25540298
citation: Riboh JC, Saltzman BM, Yanke AB, Cole BJ. Human Amniotic Membrane-Derived Products in Sports Medicine: Basic Science, Early Results, and Potential Clinical Applications. Am J Sports Med. 2016 Sep;44(9):2425-34. doi: 10.1177/0363546515612750. Epub 2015 Nov 19.
PMID: 26585668
citation: Beitzel K, McCarthy MB, Cote MP, Chowaniec D, Falcone LM, Falcone JA, Dugdale EM, Deberardino TM, Arciero RA, Mazzocca AD. Rapid isolation of human stem cells (connective progenitor cells) from the distal femur during arthroscopic knee surgery. Arthroscopy. 2012 Jan;28(1):74-84. doi: 10.1016/j.arthro.2011.06.035. Epub 2011 Oct 11.
PMID: 21996407
responsible party type: Sponsor
mesh term: Rupture